184 related articles for article (PubMed ID: 33486472)
1. Effective natural inhibitors targeting poly ADP-ribose polymerase by computational study.
Zhong S; Wu B; Yang W; Ge J; Zhang X; Chen Z; Duan H; He Z; Liu Y; Wang H; Jiang Y; Zhang Z; Wang X; Li W; Liu N; Guo X; Mou Y
Aging (Albany NY); 2021 Jan; 13(2):1898-1912. PubMed ID: 33486472
[TBL] [Abstract][Full Text] [Related]
2. Computational study on novel natural inhibitors targeting c-MET.
Hou Y; Xie H; Dou G; Yang W; Ge J; Zhou B; Ren J; Li J; Wang J; Zhang Z; Wang X
Medicine (Baltimore); 2021 Sep; 100(38):e27171. PubMed ID: 34559105
[TBL] [Abstract][Full Text] [Related]
3. Computational Study of Novel Natural Inhibitors Targeting O
Yang L; Li W; Zhao Y; Zhong S; Wang X; Jiang S; Cheng Y; Xu H; Zhao G
World Neurosurg; 2019 Oct; 130():e294-e306. PubMed ID: 31203065
[TBL] [Abstract][Full Text] [Related]
4. Computational study on new natural compound agonists of stimulator of interferon genes (STING).
Zhong S; Li W; Bai Y; Wu B; Wang X; Jiang S; Zhao Y; Ren J; Li H; Jin R
PLoS One; 2019; 14(5):e0216678. PubMed ID: 31120925
[TBL] [Abstract][Full Text] [Related]
5. Computational study of novel natural inhibitors targeting aminopeptidase N(CD13).
Ge J; Wang Z; Cheng Y; Ren J; Wu B; Li W; Wang X; Su X; Liu Z
Aging (Albany NY); 2020 May; 12(9):8523-8535. PubMed ID: 32388498
[TBL] [Abstract][Full Text] [Related]
6. Computational study on novel natural inhibitors targeting BCL2.
Lv X; Jiang Y; Wang X; Xie H; Dou G; Wang J; Yang W; Wang H; Li Z; Zhang X; Chen Z
Med Oncol; 2021 Jul; 38(8):94. PubMed ID: 34259934
[TBL] [Abstract][Full Text] [Related]
7. Effective natural inhibitors targeting IGF-1R by computational study.
Wang X; Zhou P; Lin L; Wu B; Fu Z; Huang X; Zhu D
Aging (Albany NY); 2022 Jun; 14(11):4874-4887. PubMed ID: 35680570
[TBL] [Abstract][Full Text] [Related]
8. Selected by bioinformatics and molecular docking analysis, Dhea and 2-14,15-Eg are effective against cholangiocarcinoma.
Qin L; Kuai J; Yang F; Yang L; Sun P; Zhang L; Li G
PLoS One; 2022; 17(2):e0260180. PubMed ID: 35113866
[TBL] [Abstract][Full Text] [Related]
9. In Silico Discovery of Novel Flavonoids as Poly ADP Ribose Polymerase (PARP) Inhibitors.
Shah A; Parmar G; Seth AK
Curr Comput Aided Drug Des; 2021; 17(3):344-350. PubMed ID: 32268868
[TBL] [Abstract][Full Text] [Related]
10. Computational study on natural compounds inhibitor of c-Myc.
Ren J; Huangfu Y; Ge J; Wu B; Li W; Wang X; Zhao L
Medicine (Baltimore); 2020 Dec; 99(50):e23342. PubMed ID: 33327259
[TBL] [Abstract][Full Text] [Related]
11. Design and synthesis of novel PARP-1 inhibitors based on pyridopyridazinone scaffold.
Elmasry GF; Aly EE; Awadallah FM; El-Moghazy SM
Bioorg Chem; 2019 Jun; 87():655-666. PubMed ID: 30952061
[TBL] [Abstract][Full Text] [Related]
12. Structure-Based Pharmacophore Modeling, Virtual Screening, Molecular Docking and Biological Evaluation for Identification of Potential Poly (ADP-Ribose) Polymerase-1 (PARP-1) Inhibitors.
Zhou Y; Tang S; Chen T; Niu MM
Molecules; 2019 Nov; 24(23):. PubMed ID: 31766720
[TBL] [Abstract][Full Text] [Related]
13. Novel natural inhibitors targeting B-RAF(V600E) by computational study.
Wu B; Zhang Z; Dou G; Lv X; Ge J; Wang H; Xie H; Zhu D
Bioengineered; 2021 Dec; 12(1):2970-2983. PubMed ID: 34252351
[TBL] [Abstract][Full Text] [Related]
14. Virtual screening of small molecules databases for discovery of novel PARP-1 inhibitors: combination of in silico and in vitro studies.
Ekhteiari Salmas R; Unlu A; Bektaş M; Yurtsever M; Mestanoglu M; Durdagi S
J Biomol Struct Dyn; 2017 Jul; 35(9):1899-1915. PubMed ID: 27315035
[TBL] [Abstract][Full Text] [Related]
15. Novel Target Study to Cure Cardiovascular Disease regarding Proprotein Converse Subtilisin/Kexin Type 9.
Zhao Y; Li W; Li W; Tao H; Li Y; Wu B; Wang X; Zhou H; Gao B
Biomed Res Int; 2022; 2022():9039377. PubMed ID: 36267835
[TBL] [Abstract][Full Text] [Related]
16. In silico investigation of PARP-1 catalytic domains in holo and apo states for the design of high-affinity PARP-1 inhibitors.
Salmas RE; Unlu A; Yurtsever M; Noskov SY; Durdagi S
J Enzyme Inhib Med Chem; 2016; 31(1):112-20. PubMed ID: 26083304
[TBL] [Abstract][Full Text] [Related]
17. Structure-based design of new poly (ADP-ribose) polymerase (PARP-1) inhibitors.
Chadha N; Jaggi AS; Silakari O
Mol Divers; 2017 Aug; 21(3):655-660. PubMed ID: 28653128
[TBL] [Abstract][Full Text] [Related]
18. Novel natural inhibitors targeting KRAS G12C by computational study.
Jiang Y; Chen W; Wang X; Zhou B; Xie H; Hou Y; Guo Z; Yu B; Zhong S; Su X
Anticancer Drugs; 2022 Oct; 33(9):779-788. PubMed ID: 35980001
[TBL] [Abstract][Full Text] [Related]
19. Identification of novel PARP-1 inhibitors by structure-based virtual screening.
Hannigan K; Kulkarni SS; Bdzhola VG; Golub AG; Yarmoluk SM; Talele TT
Bioorg Med Chem Lett; 2013 Nov; 23(21):5790-4. PubMed ID: 24074844
[TBL] [Abstract][Full Text] [Related]
20. In-silico method for elucidation of prodigiosin as PARP-1 inhibitor a prime target of Triple-negative breast cancer.
Sundararajan P; Dharmaraj Rajaselvi D; Vivekananthan S; Priya Ramasamy S
Bioorg Chem; 2023 Sep; 138():106618. PubMed ID: 37244231
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
